Catamaran Bio: Catamaran Bio Presents Preclinical Data Supporting Novel Engineered CAR-NK Cell Therapies For Treating Solid Tumors
- Two poster presentations at ASGCT Annual Meeting demonstrate potential of synthetic receptors to prevent TGFβ-mediated immunosuppression and enhance NK cell expansion and function - CAMB...
Read full article »
Catamaran Bio is a biotechnology company that researches and develops allogeneic CAR-NK cell therapies for the treatment of cancer.
Read more